quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:13:39·8d
SECFiling
DexCom Inc. logo

SEC Form DEFA14A filed by DexCom Inc.

DXCM· DexCom Inc.
Health Care
Original source

Companies

  • DXCM
    DexCom Inc.
    Health Care

Recent analyst ratings

  • Mar 24UpdateEvercore ISI$90.00
  • Jan 12UpdateBarclays$71.00
  • Dec 2UpdateMorgan Stanley$75.00
  • Nov 25UpdateEvercore ISI$68.00
  • Oct 21UpdateStifel$85.00
  • Sep 8UpdateOppenheimer-

Related

  • INSIDER7d
    SEC Form 4 filed by Brown Michael Jon
  • SEC8d
    SEC Form DEF 14A filed by DexCom Inc.
  • SEC8d
    SEC Form 144 filed by DexCom Inc.
  • PR21d
    Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by DexCom Inc.
  • ANALYST30d
    Dexcom upgraded by Evercore ISI with a new price target
  • INSIDER36d
    SEC Form 4 filed by Brown Michael Jon
  • PR44d
    Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022